WHOOP Secures Court Order Halting Lexqi Wearable Sales in U.S.

Event summary

  • U.S. District Court granted WHOOP a preliminary injunction against Lexqi, halting sales of Lexqi's infringing wearable product in the U.S.
  • The court found Lexqi's device 'almost identical' to WHOOP's trade dress, which has been central to WHOOP's business for over a decade.
  • WHOOP filed the lawsuit in September 2025, asserting claims under the Lanham Act and related laws.
  • The injunction aims to prevent consumer confusion and irreparable harm to WHOOP's brand.

The big picture

The injunction underscores the importance of design differentiation in the competitive wearables market. As WHOOP continues to innovate with features like cardiovascular health screening and Healthspan metrics, protecting its trade dress is critical to maintaining its market position. This legal victory could set a precedent for other companies facing similar infringement challenges, highlighting the need for genuine innovation over imitation in the health tech sector.

What we're watching

Legal Precedent
How this ruling will influence future intellectual property cases in the wearables sector.
Market Impact
Whether Lexqi will attempt to circumvent the injunction through design changes or other legal avenues.
Brand Integrity
The pace at which WHOOP can reinforce its brand authenticity and consumer trust post-ruling.